These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190 [TBL] [Abstract][Full Text] [Related]
4. Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options. Pei F; Gu B; Miao SM; Guan XD; Wu JF Chin J Traumatol; 2024 Mar; 27(2):63-70. PubMed ID: 38040590 [TBL] [Abstract][Full Text] [Related]
5. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression. Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM Front Immunol; 2022; 13():891024. PubMed ID: 35619710 [TBL] [Abstract][Full Text] [Related]
6. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression. Patil NK; Bohannon JK; Sherwood ER Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649 [TBL] [Abstract][Full Text] [Related]
7. Immune Deregulation in Sepsis and Septic Shock: Reversing Immune Paralysis by Targeting PD-1/PD-L1 Pathway. Nakamori Y; Park EJ; Shimaoka M Front Immunol; 2020; 11():624279. PubMed ID: 33679715 [TBL] [Abstract][Full Text] [Related]
8. Monitoring immunomodulation in patients with sepsis. Kyriazopoulou E; Giamarellos-Bourboulis EJ Expert Rev Mol Diagn; 2021 Jan; 21(1):17-29. PubMed ID: 33183116 [No Abstract] [Full Text] [Related]
9. Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock. Lafreniere JD; Lehmann C Metabolites; 2017 Nov; 7(4):. PubMed ID: 29104224 [TBL] [Abstract][Full Text] [Related]
10. Changes in immune function and immunomodulatory treatments of septic patients. Xu Z; Liu A; Yang L; Zhang B; Zheng F; Zhang J; Zhan J Clin Immunol; 2022 Jun; 239():109040. PubMed ID: 35569780 [TBL] [Abstract][Full Text] [Related]
11. Characterization of Early Peripheral Immune Responses in Patients with Sepsis and Septic Shock. Beltrán-García J; Osca-Verdegal R; Jávega B; Herrera G; O'Connor JE; García-López E; Casabó-Vallés G; Rodriguez-Gimillo M; Ferreres J; Carbonell N; Pallardó FV; García-Giménez JL Biomedicines; 2022 Feb; 10(3):. PubMed ID: 35327327 [TBL] [Abstract][Full Text] [Related]
12. Immunopathophysiology of human sepsis. Wiersinga WJ; van der Poll T EBioMedicine; 2022 Dec; 86():104363. PubMed ID: 36470832 [TBL] [Abstract][Full Text] [Related]
13. Sepsis Care Pathway 2019. Labib A Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206 [No Abstract] [Full Text] [Related]
15. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cao M; Wang G; Xie J Cell Death Discov; 2023 Dec; 9(1):465. PubMed ID: 38114466 [TBL] [Abstract][Full Text] [Related]
16. New perspectives on immunomodulatory therapy for bacteraemia and sepsis. Opal SM Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935 [TBL] [Abstract][Full Text] [Related]
17. Regulatory role of the programmed cell death 1 signaling pathway in sepsis induced immunosuppression. Zhong S; Yin Y Front Immunol; 2023; 14():1183542. PubMed ID: 37292207 [TBL] [Abstract][Full Text] [Related]
18. [Septic cardiomyopathy: pathophysiology and potential new therapeutic approaches]. Suzuki T; Sakai M; Yamashita S; Tomita K; Hattori Y Nihon Yakurigaku Zasshi; 2018; 151(3):111-116. PubMed ID: 29526919 [TBL] [Abstract][Full Text] [Related]